|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, Van De Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takahashi RU, Miyazaki H and Ochiya T: The
roles of microRNAs in breast cancer. Cancers (Basel). 7:598–616.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ding L, Gu H, Xiong X, Ao H, Cao J, Lin W,
Yu M, Lin J and Cui Q: MicroRNAs involved in carcinogenesis,
prognosis, therapeutic resistance and applications in human
triple-negative breast cancer. Cells. 8:14922019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Loh HY, Norman BP, Lai KS, Rahman NMANA,
Alitheen NBM and Osman MA: The regulatory role of microRNAs in
breast cancer. Int J Mol Sci. 20:49402019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoshiko Y and Aubin JE: Stanniocalcin 1 as
a pleiotropic factor in mammals. Peptides. 25:1663–1669. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin F, Li X and Wang X, Sun H, Wang Z and
Wang X: Stanniocalcin 1 promotes metastasis, lipid metabolism and
cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in
ovarian cancer. J Exp Clin Cancer Res. 41:1292022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bai S, Zhao Y, Chen W, Peng W, Wang Y,
Xiong S, Arun A, Li Y, Yang Y, Chen S, et al: The stromal-tumor
amplifying STC1-Notch1 feedforward signal promotes the stemness of
hepatocellular carcinoma. J Transl Med. 21:2362023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang AC, Doherty J, Huschtscha LI,
Redvers R, Restall C, Reddel RR and Anderson RL: STC1 expression is
associated with tumor growth and metastasis in breast cancer. Clin
Exp Metastasis. 32:15–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu A, Li Y, Lu S, Cai C, Zou F and Meng
X: Stanniocalcin 1 promotes lung metastasis of breast cancer by
enhancing EGFR-ERK-S100A4 signaling. Cell Death Dis. 14:3952023.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chandran UR, Medvedeva OP, Barmada MM,
Blood PD, Chakka A, Luthra S, Ferreira A, Wong KF, Lee AV, Zhang Z,
et al: TCGA expedition: A data acquisition and management system
for TCGA data. PLoS One. 11:e01653952016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lasham A, Fitzgerald SJ, Knowlton N, Robb
T, Tsai P, Black MA, Williams L, Mehta SY, Harris G, Shelling AN,
et al: A predictor of early disease recurrence in patients with
breast cancer using a cell-free RNA and protein liquid biopsy. Clin
Breast Cancer. 20:108–116. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Zhang W, Ding Z, Xu T, Zhang X and
Xu K: Comprehensive exploration of the expression and prognostic
value of AQPs in clear cell renal cell carcinoma. Medicine
(Baltimore). 101:e293442022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yao Y, Chu Y, Xu B, Hu Q and Song Q: Risk
factors for distant metastasis of patients with primary
triple-negative breast cancer. Biosci Rep. 39:BSR201902882019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
De Laurentiis M, Cianniello D, Caputo R,
Stanzione B, Arpino G, Cinieri S, Lorusso V and De Placido S:
Treatment of triple negative breast cancer (TNBC): Current options
and future perspectives. Cancer Treat Rev. 36 (Suppl 3):S80–S86.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu M, Wang G, Tian W, Deng Y and Xu Y:
MiRNA-based therapeutics for lung cancer. Curr Pharm Des.
23:5989–5996. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mishra S, Yadav T and Rani V: Exploring
miRNA based approaches in cancer diagnostics and therapeutics. Crit
Rev Oncol Hematol. 98:12–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Heneghan HM, Miller N, Lowery AJ, Sweeney
KJ, Newell J and Kerin MJ: Circulating microRNAs as novel minimally
invasive biomarkers for breast cancer. Ann Surg. 251:499–505. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang AC, Jeffrey KJ, Tokutake Y,
Shimamoto A, Neumann AA, Dunham MA, Cha J, Sugawara M, Furuichi Y
and Reddel RR: Human stanniocalcin (STC): Genomic structure,
chromosomal localization, and the presence of CAG trinucleotide
repeats. Genomics. 47:393–398. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Madsen KL, Tavernini MM, Yachimec C,
Mendrick DL, Alfonso PJ, Buergin M, Olsen HS, Antonaccio MJ,
Thomson AB and Fedorak RN: Stanniocalcin: A novel protein
regulating calcium and phosphate transport across mammalian
intestine. Am J Physiol. 274:G96–G102. 1998.PubMed/NCBI
|
|
24
|
Chang AC, Jellinek DA and Reddel RR:
Mammalian stanniocalcins and cancer. Endocr Relat Cancer.
10:359–373. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deol HK, Varghese R, Wagner GF and
Dimattia GE: Dynamic regulation of mouse ovarian stanniocalcin
expression during gestation and lactation. Endocrinology.
141:3412–3421. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zlot C, Ingle G, Hongo J, Yang S, Sheng Z,
Schwall R, Paoni N, Wang F, Peale FV Jr and Gerritsen ME:
Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic
responses to hepatocyte growth factor. J Biol Chem.
278:47654–47659. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Block GJ, Ohkouchi S, Fung F, Frenkel J,
Gregory C, Pochampally R, DiMattia G, Sullivan DE and Prockop DJ:
Multipotent stromal cells are activated to reduce apoptosis in part
by upregulation and secretion of stanniocalcin-1. Stem Cells.
27:670–681. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan X, Jiang B, Liu J, Ding J, Li Y, Sun
R, Peng L, Qin C, Fang S and Li G: STC1 promotes cell apoptosis via
NF-κB phospho-P65 Ser536 in cervical cancer cells. Oncotarget.
8:46249–46261. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peña C, Céspedes MV, Lindh MB, Kiflemariam
S, Mezheyeuski A, Edqvist PH, Hägglöf C, Birgisson H, Bojmar L,
Jirström K, et al: STC1 expression by cancer-associated fibroblasts
drives metastasis of colorectal cancer. Cancer Res. 73:1287–1297.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leung CC and Wong CK: Effects of STC1
overexpression on tumorigenicity and metabolism of hepatocellular
carcinoma. Oncotarget. 9:6852–6861. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen F, Zhang Z and Pu F: Role of
stanniocalcin-1 in breast cancer. Oncol Lett. 18:3946–3953.
2019.PubMed/NCBI
|
|
32
|
Murai R, Tanaka M, Takahashi Y,
Kuribayashi K, Kobayashi D and Watanabe N: Stanniocalcin-1 promotes
metastasis in a human breast cancer cell line through activation of
PI3K. Clin Exp Metastasis. 31:787–794. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
McCudden CR, Majewski A, Chakrabarti S and
Wagner GF: Co-localization of stanniocalcin-1 ligand and receptor
in human breast carcinomas. Mol Cell Endocrinol. 213:167–172. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Joensuu K, Heikkilä P and Andersson LC:
Tumor dormancy: Elevated expression of stanniocalcins in late
relapsing breast cancer. Cancer Lett. 265:76–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Avalle L, Raggi L, Monteleone E, Savino A,
Viavattene D, Statello L, Camperi A, Stabile SA, Salemme V, De
Marzo N, et al: STAT3 induces breast cancer growth via ANGPTL4,
MMP13 and STC1 secretion by cancer associated fibroblasts.
Oncogene. 41:1456–1467. 2022. View Article : Google Scholar : PubMed/NCBI
|
